<DOC>
	<DOCNO>NCT01735773</DOCNO>
	<brief_summary>The investigator aim study effect prohepcidin level hematologic parameter inflammatory marker non-diabetic uremic patient . The investigator select three group patient : Hemodialysis group , peritoneal dialysis group group stage 4 chronic kidney disease . A control group form healthy volunteer also . Each group plan form 25 patient . Diabetic patient exclude . Prohepcidin , hsCRP , IL-6 , fibrinogen plan study besides routine biochemical analysis include hematological one .</brief_summary>
	<brief_title>Role Prohepcidin Uremic Patients</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hepcidins</mesh_term>
	<criteria>hemodialysis peritoneal dialysis patient dialysis therapy 3 month , age 1880 year , patient creatinine clearance 1530 ml/min . age less 18 80 , diabetic patient , current active infectious inflammatory disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>hemodialysis</keyword>
	<keyword>inflammation</keyword>
	<keyword>iron</keyword>
	<keyword>peritoneal dialysis</keyword>
	<keyword>prohepcidin</keyword>
	<keyword>uremia</keyword>
</DOC>